chrisvoncsefalvay/vaers-outcomes huggingface dataset:
From the time of vaccine until first onset of symptoms was approx five hours. Fever of 104, chills that felt like a seizure, headache that was blinding - worst I've ever had, and I have a history of migraines. Was not a migraine, was worse. Body aches. Over the next three days, I got worse. Went to the ER, sent home, went back two days later and was admitted for four days. Same symptoms, with the addition of pneumonia and sepsis.
Vaccinee is one of five employees who have been identified as non responders following a series of three Engerix-B inject.
Started itching the night of administration with redness. The following morning we note swelling and heat, beatter today (10/15/15), used BENADRYL top/BENADRYL PO.
Information has been received form a consumer concerning a patient who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt developed chickenpox. Medical attention was not sought. A product quality complaint was not involved. Additional info has been requested.
vomiting, lethargy, listlessness, extreme irritability, dec intake of formula, greenish black tarry BM, inc sleep;
Fatigue 2-3 hours after vaccination.  Sweating/elevated heart rate about 11 hours after vaccine. Severe Headache 11 hours after vaccination.
Patient received smallpox and anthrax vaccine on 29 July 2017 for upcoming job. Pregnancy test at date of vaccination was negative. Patient reported to me on 18 August 2017 that a subsequent pregnancy test done at home approximately 10 days later was positive. Pregnancy testing completed on 18 August 2018 in the clinic was positive. Patient estimated date of conception to be 19 July 2017 and was pending evaluation by OB-GYN. Patient denied adverse symptoms beyond local reaction, mild aches, pain, low grade temp expected with smallpox and anthrax reaction and was doing well during our initial follow up beyond concerns for developing fetus. Patient reported that she started prenatal vitamins, stopped smoking and stopped con.
unable to apply pressure on leg while walking x 2 days  Fever for 2 days
Patient passed out from standing position about 5 minutes after administration of influenza vaccination. Pt hit head on floor so EMT were called to be evaluated. Pt was then released by EMTS. Pt reports passing out previously from giving blood (>3 occasions).
stroke; he had a headache and blurred vision the day of vaccination; he had a headache and blurred vision the day of vaccination; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "stroke"; HEADACHE (non-serious), VISION BLURRED (non-serious), outcome "unknown" and all described as "he had a headache and blurred vision the day of vaccination". Additional information: Patients' wife stated that he had a headache and blurred vision the day of vaccination. Then a week later had a stroke.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the database from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Chronic headache beginning ~2 weeks after the vaccination and continuing for roughly 2 full weeks after; pain level 2-3 out of 10.  No treatment administered regularly, ibuprofen taken one time.  Headaches have been reported through last week and seem to have subsided as of a few days ago.  Onset of chronic tinnitus and individual "tinnitus events" roughly ~2 weeks after vaccination.    7 "tinnitus events" have been experienced where the patient reports rapid onset auditory muting in one or both ears with the onset of an audible frequency and will persist for roughly 5 seconds before quickly fading.  The frequency has been both low frequency as well has high frequency during different events, and this has happened in each ear individually as well as both ears, random between events.  The most recent tinnitus event happened yesterday, so the condition is ongoing.  Chronic tinnitus has been reported as well, with a mild case of constant high-pitched tinnitus (roughly 8khz tone) that has continued from 2 weeks post vaccination to today.
itchy, blotchy spots, headache, chills,  skin aches, muscle aches, light headed, dizzy, extreme fatigue, nausea full symptoms lasted 72 hours  sleep, fluids, tylenol and benedryl were taken  dull headache and body aches and fatigue still present after 72 hours
fever of 1 wk duration 101.0, hypesthesia, arthralgias-whole body;hypersensitivity of the skin;vomiting, nausea x 2 days;
4am nausea, sweating, headache, arm pain, continuing until 8pm  Could not physically get out of bed until 12pm. So exhausted after regular shower, slept additional hour. Could not eat for nausea. Spent nearly entire day in bed with maybe 2 active hours.
Dizziness  04/07/2021 & 04/08/2021 Tired 04/08/2021 Muscle Weakness  04/07/2021 & 04/08/2021 Muscle Cramps 04/07/2021 Lower Back  Pain and Sides 04/07/2021 & 4/08/2021 Headache by Right eye 04/07/2021 Burning in left shoulder to the side of my neck 04/06/2021
Ringing in the L ear, heaviness, L sided headache, L earache, feeling sensation of needing to ?pop? but cannot
Facial rash, redness and hot to the touch. Roseacia like; redness; hot to the touch; Roseacia like; This is a spontaneous report from a contactable consumer. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) in the left arm on 11May2021 at 11:00(at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included colitis ulcerative. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN), methylprednisolone (MEDROL), guaifenesin, pseudoephedrine hydrochloride (SUDAFED), fluticasone propionate (FLONASE) and montelukast sodium (SINGULAR) started on an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation On 12May2021 at 07:00 the patient experienced facial rash, redness, hot to the touch and roseacia like. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events facial rash, redness, hot to the touch and roseacia like was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
I had breathing problems after vaccination and had seizure. I was taken to the hospital by the ambulance on 12/21/2021. I was taken to Medical center on 12/21/2021. Then was taken to behavioral health center and then was diagnosed with sinusitis acute, Psychosis acute, bipolar type acute and Schizoaffective disorder. Also depression and anxiety as diagnosed by the psychologists.
No adverse event; Vaccine administered after beyond use date (BUD); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (BUD)) and NO ADVERSE EVENT (No adverse event) in a 4-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (BUD)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (BUD)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (BUD)).    No concomitant medications were reported. The vaccine was received at the clinic on 07-Jun-2022. The vaccine BUD was reported as 07-Jul-2022. No treatment information was provided.
extreme fatigue. Rest has been recommended and practiced. Fatigue symptoms are still present by 3/21/21.
Patient stated she felt like she was going to pass out. Requested for water ad fresh air. After receiving water and fresh air  patient stated she felt better. Patient refused transport to ED. Patient 31 weeks at present time
Developed temp mom tx Panadol q4hrs the rest of the day & night;Became lethargic, vomited x 1;
High fever for 4 days 102.60 / nauseated lightheaded / headache.  Only needed tetanus booster but County only had Tdap, so had to get that vaccine.  She was trying to get over major injury an then also had to deal with additional stress of the vaccine/adverse reaction.
MILD FEVER; This spontaneous report received from a vaccine facility concerned a 25 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.   No concomitant medications were reported. On 02-APR-2021, the subject experienced mild fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild fever was not reported. This report was non-serious.
(L) arm was sore after injection. No redness or swelling but has consistently become more painful in deltoid area radiating toward elbow and into hand.
Fever 103 F Chills Diarrhea Nausea Abdominal pain Back pain  Right leg severe pain and numbness  Neck pain
Fever, vomiting, pain, sweating/chills, dizzy when standing since 5:00pm yesterday.
Blistering rash; One hell of a rash / irritating rash; Injection site has become dark purplish spot; Itching so bad all around the rash area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area), BLISTER (Blistering rash) and RASH (One hell of a rash / irritating rash) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Aspirin.).    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jun-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area) and RASH (One hell of a rash / irritating rash). On an unknown date, the patient experienced BLISTER (Blistering rash). At the time of the report, VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area), BLISTER (Blistering rash) and RASH (One hell of a rash / irritating rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No treatment medications were reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up received on 18-Jun-2021 contains no new information (NNI)
Shot give on left leg on 07/03/02, On 07/09/02, site was red, swollen, slight warm to touch, target lesion, erythema, raised, slight tender 3 X 3 in size,  07/05/2002 Advised to use Motrin and ice compresses.
The Varicella vaccine completely failed me, I broke out with a severe case of chicken pox, 102 fever.  CDC websites says a vaccinated person could contract a mild case, less than 50 blisters.  I have 50 on my face alone, and they are covering my entire body, I estimate there are hundred on my body. I have bad scalp pain. I did recieve two rounds of this vaccine and believed I had immunity.  There is no suggestion of a booster.  I want to report this as I was the first round of people to receive this in the US and maybe the CDC should be suggesting a booster.
Information has been received from an investigator concerning the following report: AN# 100410 BL# 0009-00011, a 1 year old male with anemia and reportedly underweight (beginning 17-JAN-2013) and a medical history of jaundice (from September to November of 2011), viral infection (from 25-DEC-2012 to 26-DEC- 2012) and bronchiolitis RSV (from 07-JAN-2013 to 21-JAN-2013) who on 14- SEP-2012 was randomized to study. On 14-SEP-2012, the patient was placed on a study therapy for the prophylactic treatment of MMRV. Concomitant therapy includes albuterol sulfate and acetaminophen. On 23-JAN-2013, the patient reportedly started to vomit. The patient had previous episodes of diarrhea beginning 17-DEC-2012 that had not fully resolved and begin again on 24-JAN-2013. The patient was having episodes of diarrhea roughly 1 time every hour with no blood but sometimes "mucousy" in color. The patient was not eating or drinking well, so on 25-JAN-2013, the patient was taken to the emergency room by his mother. In the ER, the patient was diagnosed with viral gastritis, metabolic acidosis, hypoglycemia, severe dehydration, poor weight gain and chronic diarrhea. The patient was admitted to the hospital the same day. Upon admittance, the patient was given an IV with a total of 180 milligrams of normal saline. Prior to the dose of saline, the patient's glucose performed 25-JAN-2013, showed an abnormal result of 56. The glucose result taken after the administration of normal saline showed a result of 123. This result is considered normal by the reporting investigator. The patient was reportedly discharged home on 26-JAN-2013. No further details related to the patient's current clinical status was provided at this submission. The serious adverse event of chronic diarrhea was considered recovered on 26-JAN-2013. The events of poor weight gain, severe dehydration, hypoglycemia, metabolic acidosis, and viral gastroenteritis are considered not recovered. The patient received an additional dose of study therapy of on 17-DEC-2012. No action was taken with blinded study therapy as a result of the event. At the time of the event, the patient had complete study therapy dosing and no further doses were scheduled. The relationship of the events to study therapy was not provided at the time of this report. This case was unblinded on 06-FEB-2013. Additional information is expected.
Diagnosed with COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID-19) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0401L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID-19). At the time of the report, COVID-19 (Diagnosed with COVID-19) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. Treatment include Steroids and Antibiotics
Information has been received from a nurse referring to a patient of unknown age and gender. On 21-MAY-2015 the patient was inadvertently administered an expired dose of PNEUMOVAX23 (lot # K005957, expiration date: 08-MAR-2015, 0.5 ml, once, intramuscular) (expired product administered). No adverse effect reported. Additional information has been requested.
No additional AEs; Healthcare worker reported that a patient received an expired PNEUMOVAX; The vaccine also had an temperature excursions prior to the administration; This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 05-OCT-2022, the patient was vaccinated with an expired and improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 1 dose, lot #t040202, expiration date: 11-SEP-2022, administered for prophylaxis (anatomical location and route of administration were not provided) (expired product administered, product storage error). The suspect vaccine's temperature excursions prior to administration occurred on 14-MAY-2022, at a temperature of 52.7 degrees (deg.) Fahrenheit (F) for a time frame of 1 hour 30 minutes, and on 24-JUL-2022, at a temperature of 51.6 deg. F for a time frame of 50 minutes.  No additional adverse events (AEs) were reported (no adverse event).  This is a non-valid case due to lack of patient identifiers.  Follow-up information has been received on 01-DEC-2022 from an other health professional, referring to a 83-year-old female patient. The patient's concomitant vaccines included influenza vaccine inact split 3v (FLUZONE HIGH DOSE). The patient was administered pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe, first dose (number of previous doses reported as "0"), lot # provided as "T040202 PP", intramuscularly (IM) in right deltoid (RD). It was reported that a staff error occurred: staff data entry error of expiration date into electronic medical records (EMR), and shot giver didn't check syringe expiration date. The reporter indicated that the error occurred at administration, as staff did not check expiration date on syringe and data entry error in EMR was showing expiration date in 2023. No prescription drug treatment was required for the experience. The outcome of staff error regarding the use of an expired vaccine was provided as resolved/recovered with sequelae (considered the outcome of expired product administered, with stop date of ??-???-2022).
p/vax pt exp 6.5 x 7cm red area, sl indurated, not warm on the lt arm;instructed to give DPH;pt was seen on 4/18/98;
CLIENT PRESENTS IN CLINIC TODAY WITH VARICELLA RASH.  FEW LESIONS ON ARM AND CHEST.  MOM REPORTS SHE NOTICED HER SON ON MAY 15 BREAKING OUT IN RASH ON HIS CHEST AND SPREADING TO HIS ARMS LEGS AND BACK. HE ALSO COMPLAINED WITH ITCHING MOM TOOK CLIENT TO DR TODAY  DR DX VARICELLA RASH REACTION TO VARICELLA VACCINE TREATED IN OFC WITH BENADRYL INJECTION
SHE FELT NAUSEOUS AND WAS  VOMITING AND  MUSCLE SORNESS  ON INSIDE OF THE FOOT AND MUSCLE CRAMPING AND FEVERISH THAT AROSE 1 HOUR AFTER INJECTION. 12:45 INJECTION AND 1:45 SYMPTOMS STARTED.
Breakthrough case admission after third dose Pfizer 2/24/21 Lot# EN6202 Pfizer 3/17/21 Lot# EN6204 Moderna 12/23/21 Lot# 013H21B
Cellulitis to Left thigh began 12/5/17. ER visit at 12AM 12/6/17 for fever Tmax 103 and increasing warmth, redness, swelling. Also increasing pain in left leg. Discharge to home with BACTRIM and CLEOCIN x 10 days.
No additional AE reported; Caller is a office manager calling to report a temperautre excursion for VARIVAX. Caller reports that one dose of VARIVAX was administered to the patient on 19SEP2022; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender.  The patient's pertinent concurrent conditions, medical history, drugs reactions or allergies and concomitant medications were not provided.  On 19-SEP-2022, the patient was vaccinated with one dose of improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number U030161 has been verified to be a valid lot number with expiration date on 28-SEP-2023, administered as prophylaxis (strength, dose, vaccination scheme, route of administration and anatomical location was not provided).  The varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature of 75-degree Fahrenheit, for an unknown time frame (product storage error). There was no previous temperature excursion, but It was reported that the excursion was still ongoing.  No additional adverse events were reported.
chills; uncontrollable body shaking; uncontrollable hands shaking; fever; fatigue; sore arm; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, MACROGOL 3350 (MIRALAX), CALCIUM and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache). At the time of the report, CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Began with redness at each injection site, rash extending trunk, cough, afebrile. Seen at MD and prednisone ordered.
After breastfeeding my daughter for 7 months I never got my period back so when she turned 1 year old in March 2022 I went to my OBGYN to get some bloodwork done (2 rounds of testing done in April and May) only to learn that my estrogen was super low and my FSH and LH were very high (this has never been a problem for me before and I had no issues getting pregnant with my daughter - I have also always had a regular period for as long as I can remember).  She said it could be indicative of premature ovarian failure and from there I went to see a fertility clinic who did more tests and said it could be low ovarian reserve or premature ovarian failure). I also got back on birth control since my estrogen was so low in July and then got off of it after 3 months (I did get my period while on my BC which I was told is uncommon if you are in the menopausal category which I thought was interesting)  to see if I was able to get my period back on it's own.  Unfortunately I didn't get my period in September and went to another fertility clinic for a second opinion who did more blood tests after I had been off my BC for a month. I am waiting for the final set of test and lab results from them.
c/o feeling strange p/receiving vax this PM itchy feeling over body; heaviness in arms, malaise; c/o dizziness-itching all over; color pale; c/o feeling very sleepy; nausea; allergic reaction;